Unknown

Dataset Information

0

Secreted Expression of mRNA-Encoded Truncated ACE2 Variants for SARS-CoV-2 via Lipid-Like Nanoassemblies.


ABSTRACT: The transfer of foreign synthetic messenger RNA (mRNA) into cells is essential for mRNA-based protein-replacement therapies. Prophylactic mRNA COVID-19 vaccines commonly utilize nanotechnology to deliver mRNA encoding SARS-CoV-2 vaccine antigens, thereby triggering the body's immune response and preventing infections. In this study, a new combinatorial library of symmetric lipid-like compounds is constructed, and among which a lead compound is selected to prepare lipid-like nanoassemblies (LLNs) for intracellular delivery of mRNA. After multiround optimization, the mRNA formulated into core-shell-structured LLNs exhibits more than three orders of magnitude higher resistance to serum than the unprotected mRNA, and leads to sustained and high-level protein expression in mammalian cells. A single intravenous injection of LLNs into mice achieves over 95% mRNA translation in the spleen, without causing significant hematological and histological changes. Delivery of in-vitro-transcribed mRNA that encodes high-affinity truncated ACE2 variants (tACE2v mRNA) through LLNs induces elevated expression and secretion of tACE2v decoys, which is able to effectively block the binding of the receptor-binding domain of the SARS-CoV-2 to the human ACE2 receptor. The robust neutralization activity in vitro suggests that intracellular delivery of mRNA encoding ACE2 receptor mimics via LLNs may represent a potential intervention strategy for COVID-19.

SUBMITTER: Li M 

PROVIDER: S-EPMC8420471 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Secreted Expression of mRNA-Encoded Truncated ACE2 Variants for SARS-CoV-2 via Lipid-Like Nanoassemblies.

Li Min M   Li Sanpeng S   Huang Yixuan Y   Chen Haixia H   Zhang Songya S   Zhang Zhicheng Z   Wu Weigang W   Zeng Xiaobin X   Zhou Boping B   Li Bin B  

Advanced materials (Deerfield Beach, Fla.) 20210718 34


The transfer of foreign synthetic messenger RNA (mRNA) into cells is essential for mRNA-based protein-replacement therapies. Prophylactic mRNA COVID-19 vaccines commonly utilize nanotechnology to deliver mRNA encoding SARS-CoV-2 vaccine antigens, thereby triggering the body's immune response and preventing infections. In this study, a new combinatorial library of symmetric lipid-like compounds is constructed, and among which a lead compound is selected to prepare lipid-like nanoassemblies (LLNs)  ...[more]

Similar Datasets

| S-BSST649 | biostudies-other
| EMPIAR-11181 | biostudies-other
| S-SCDT-10_15252-EMBR_202256374 | biostudies-other
| S-EPMC7989403 | biostudies-literature
| S-EPMC9581196 | biostudies-literature
| S-EPMC9349794 | biostudies-literature
| S-EPMC9094100 | biostudies-literature
| S-EPMC9731714 | biostudies-literature
| EMPIAR-11180 | biostudies-other
| EMPIAR-11179 | biostudies-other